Skip to content
healthcare.dev
Get a free key

Risedronate Sodium

NDC 59762-0406, Risedronate Sodium, tablet, film coated, from Mylan Pharmaceuticals, Inc..

Product NDC
59762-0406
Status
Listed
Labeler
Mylan Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020835
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59762-0406 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM HEMIPENTAHYDRATE129 mg/1
  • RISEDRONATE SODIUM MONOHYDRATE21 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Bisphosphonate [EPC]; Diphosphonates [CS]; Diphosphonates [CS]

Package NDCNDC-11Package
59762-0406-1597620406011 TABLET, FILM COATED in 1 DOSE PACK (59762-0406-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f715718a-407d-4e2a-9834-74a8f1361d03

  • NADAC price for package 59762040601

    GET /v1/drugs/nadac/59762040601

Use it

Look up 59762-0406 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59762-0406 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59762-0406. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.